blocks coins money
Pharma

Editor’s Corner: Why an AZ-BMS merger would be a very bad idea

A merger risks severe regulatory concerns, pipeline disruptions and layoffs, while damaging the broader biopharma ecosystem, argues Fierce's Angus Liu
Angus Liu Aug 3, 2026 12:25am
Why the Real Risk in Hub Transition is Inertia

What Hub Transitions Really Cost Manufacturers

Brought to you by Gifthealth
MA
Favicon Fierce Biotech

Curium strikes up to $8B deal for radiopharma rival Lantheus

Aug 3, 2026 2:20pm
A chessboard with blocks that read MA

Supernus-Indivior merger is about scale, business development

Aug 3, 2026 11:20am
Data security and privacy concept

Amgen says patient data, IP stolen in cybersecurity breach

Aug 3, 2026 11:05am
Law Legal System Justice Crime concept Mallet Gavel Hammer and Scales on tabl

Sandoz inks dual settlements to resolve most US antitrust claims

Aug 3, 2026 10:18am
More News

Novartis' Pluvicto unlocks substantial new patient pool

Aug 3, 2026 8:33am
Fierce Biotech

After 5-month wait, BioNTech reveals Sobi CEO will take top job

Aug 3, 2026 7:35am

Amylyx demystifies post-bariatric hypoglycemia

Jul 31, 2026 2:17pm
Fierce Healthcare

Revised 340B Rebate Model Pilot Program moves forward

Jul 31, 2026 1:15pm